+Search query
-Structure paper
| Title | Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin alpha-FAPx4-1BB: A preclinical study in multiple myeloma. |
|---|---|
| Journal, issue, pages | Biomed Pharmacother, Vol. 176, Page 116877-116877, Year 2024 |
| Publish date | May 6, 2024 (structure data deposition date) |
Authors | Saltarella, I. / Link, A. / Lamanuzzi, A. / Reichen, C. / Robinson, J. / Altamura, C. / Melaccio, A. / Solimando, A.G. / Ria, R. / Mariggio, M.A. ...Saltarella, I. / Link, A. / Lamanuzzi, A. / Reichen, C. / Robinson, J. / Altamura, C. / Melaccio, A. / Solimando, A.G. / Ria, R. / Mariggio, M.A. / Vacca, A. / Frassanito, M.A. / Desaphy, J.F. |
External links | Biomed Pharmacother / PubMed:38850654 |
| Methods | X-ray diffraction |
| Resolution | 2.81 Å |
| Structure data | ![]() PDB-9f7z: |
| Chemicals | ![]() ChemComp-NAG: ![]() ChemComp-HOH: |
| Source |
|
Keywords | PROTEIN BINDING / Tumor necrosis factor receptor superfamily member 9; 4-1BB; TNFRSF9; DARPin; designed ankyrin repeat protein; immune-oncology; Molecular Partners AG; Proteros Biostructures GmbH |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links


homo sapiens (human)
Keywords